Daejeon Mounjaro - 비에이의원 대전 둔산동 피부과

What is Daejeon Mounjaro? It is an obesity treatment whose main ingredient is Tirzepatide, a GLP-1/GIP dual agonist.

It is an obesity treatment from the American pharmaceutical company Eli Lilly that can manage blood sugar and lose weight simultaneously.

Daejeon Mounjaro Recommended For:

Individuals who have tried various diets with minimal results
Individuals who have difficulty controlling appetite, binge eating, or late-night eating
Individuals who want to manage both weight and blood sugar
Individuals requiring medication and professional medical supervision

To receive Mounjaro prescription in a medical setting, specific medical guidelines set by the Ministry of Food and Drug Safety must be met.
- Body Mass Index (BMI) Criteria: Prescription is available for obese patients with a BMI of 30 kg/㎡ or higher.
- In cases of Comorbidities: Prescription may be considered for individuals with a BMI of 27 kg/㎡ or higher who also have one or more weight-related complications such as hypertension, type 2 diabetes, or dyslipidemia.
- Therefore, it is excluded from prescription targets for individuals who are simply within the standard weight range or only mildly overweight.

Sufficient Moisturization

As temporary dryness may occur, it is advisable to pay attention to moisturizing.

Minimize Irritants

Activities such as strenuous exercise or prolonged sauna use can cause heat and inflammation in the skin.

Regular Follow-up

It is recommended to periodically check if recovery is proceeding normally after your visit.

Most Common Side Effects: Nausea, vomiting, abdominal discomfort

Generally adapt and improve over time

Rarely, constipation, diarrhea, headache, fatigue, etc.

Very rarely, serious side effects such as pancreatitis can occur, making specialist consultation and monitoring essential.

instagram.com/baclinic_daejeon